Special Section on Cytochrome P450 Enzymes in Toxicology and as Drug Targets—Editorial
Author:
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Reference5 articles.
1. Beers JL Zhou Z Jackson KD (2024) Advances and challenges in modeling cannabidiol pharmacokinetics and hepatotoxicity. Drug Metab Dispos 52:508–515 DOI: 10.1124/dmd.123.001435.
2. Guengerich FP (2024) Cytochrome P450 enzymes as drug targets in human disease. Drug Metab Dispos 52:493–497 DOI: 10.1124/dmd.123.001431.
3. Kowalski JP Rettie AE (2024) There and back again: a perspective on 20 years of CYP4Z1. Drug Metab Dispos 52:498–507 DOI: 10.1124/dmd.124.001670.
4. Latham BD Geffert RM Jackson KD (2024) Kinase inhibitors FDA-approved 2018-2023: drug targets, metabolic pathways, and drug-induced toxicities. Drug Metab Dispos 52:479–492 DOI: 10.1124/dmd.123.001430.
5. Work HM Hackett JC Lampe JN (2024) HCV antiviral drugs have the potential to adversely perturb the maternal-fetal communication axis through inhibition of CYP3A7 DHEA-S oxidation. Drug Metab Dispos 52:516–525 DOI: 10.1124/dmd.123.001434.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3